Insider Transactions in Q2 2023 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
Asit Parikh |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+24.0%
|
$105,000
$7.4 P/Share
|
|
Jun 02
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
1,960
-2.78%
|
$21,560
$11.41 P/Share
|
|
May 25
2023
|
Mark Stenhouse |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+50.0%
|
-
|
|
May 25
2023
|
James N Topper |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+29.42%
|
-
|
|
May 25
2023
|
Asit Parikh |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+21.69%
|
-
|
|
May 25
2023
|
David A Socks |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+50.0%
|
-
|
|
May 25
2023
|
Heidi Fields |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+50.0%
|
-
|
|
May 25
2023
|
Michael F Cola |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+32.38%
|
-
|
|
May 25
2023
|
Frank Karbe |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+50.0%
|
-
|
|
May 22
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
2,110
-2.91%
|
$25,320
$12.87 P/Share
|
|
Apr 11
2023
|
Azmi Nabulsi Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.13%
|
$80,000
$8.26 P/Share
|
|
Apr 10
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
1,000
+4.08%
|
$7,000
$7.55 P/Share
|
|
Apr 06
2023
|
Terrie Curran President and Chief Executive |
BUY
Open market or private purchase
|
Direct |
12,919
+6.42%
|
$90,433
$7.82 P/Share
|
|
Apr 06
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
3,439
-4.52%
|
$24,073
$7.27 P/Share
|